VTR - Ventas, Inc.

NYSE - NYSE Delayed Price. Currency in USD
+0.60 (+0.98%)
At close: 4:01PM EDT

61.68 0.00 (0.00%)
After hours: 5:15PM EDT

Stock chart is not supported by your current browser
Previous Close61.08
Bid61.51 x 900
Ask61.70 x 1000
Day's Range60.61 - 62.05
52 Week Range46.55 - 65.70
Avg. Volume2,110,885
Market Cap22.154B
Beta (3Y Monthly)0.56
PE Ratio (TTM)54.11
EPS (TTM)1.14
Earnings DateApr 25, 2019 - Apr 29, 2019
Forward Dividend & Yield3.17 (5.15%)
Ex-Dividend Date2019-03-29
1y Target Est61.09
Trade prices are not sourced from all markets
  • InvestorPlace6 hours ago

    Invest in America’s Rising Healthcare Costs With These Stocks

    Not a day goes by that healthcare costs aren't being discussed across each corner of media. With the 2020 election now underway, politicos are ratcheting up the rhetoric over healthcare costs and the political ads are already spinning the topic. And all of this is for good reason. Healthcare costs in the U.S. are high and rapidly rising, especially if you're of retirement age. According to the U.S. Centers for Medicare and Medicaid Services (CMS) -- healthcare spending increased in 2017 by 3.90% to $3.9 trillion or $10,739 per person. This represents 17.90% of the then gross domestic product of the U.S. (GDP). In fact, in a recently published book, More than Medicine: The Broken Promise of American Health by Bob Kaplan, he argues that the U.S. pays way more than its mature economic peers.For example, the U.S. pays 18% of its gross domestic product (GDP) on healthcare whereas the European Union (E.U.) only pays 10% of its combined GDP. And, to make it worse, the U.S. has a lower life expectancy than many nations around the globe. Add in a high poverty rate, which can lead to further health challenges for young and old and other factors showing health troubles, including infant mortality, and the nation doesn't look too healthy. American healthcare may well get even more expensive, as the U.S. ages and becomes less healthy by the day. This isn't a good mix for one of the leading economies of the planet.In a recent study by the U.S. Department of Commerce and the U.S. Census, by 2035, it is projected that 78 million folks will be 65 years or older. That same year, those at or under the age of 18 years will number just 76 million. America is becoming a nation of the elderly -- a significant change in the demographics of a nation traditionally known for its healthy and able folks. It's a shift that leaves many wondering where our economic productivity gains will come from. And, as we know, the elderly population requires the most attentive healthcare … no wonder healthcare spending is climbing.InvestorPlace - Stock Market News, Stock Advice & Trading Tips * 10 Stocks on the Rise Heading Into the Second Quarter While this sounds bleak, there is a silver lining here for us as investors. And no, I'm not suggesting that we look at gym companies (although I am poking around at that market with some innovations that I'll be writing about in Profitable Investing in the near future). Rather, I'm suggesting that investing in healthcare stocks that pay dividends is a smart source for capital gains … WP Carey Click to Enlarge Source: Bloomberg One healthcare stock, in particular, comes to mind … I'm referring to WP Carey (NYSE:WPC), which I've written about extensively for InvestorPlace.WP Carey is a REIT, which since coming to the public market, has generated a return of 1,348.28% for an average annual equivalent return of 13.46%. That's not too shabby any way you cut it. The business itself is a curious one: WP Carey doesn't operate its properties, and it doesn't pay for maintenance, insurance, or taxes. Instead, it executes "triple net leases." This means that it locks up long-term cashflows with less risk in rising costs for the properties and the vagrancies of tax rates.Its tenants pay for all of that, thus WP Carey profits from other peoples' money.In the healthcare market, there is a specific equivalent in the following security. Well, this next security is technically a real estate investment trust (REIT) that owns and acquires healthcare facilities including inpatient and outpatient facilities as well as surgical centers and specialty healthcare facilities. Their properties amount to more than 120 properties in 25 states as well as some newer innovative investments in Germany. Scroll down to discover what it is … Medical Properties Trust (MPW) Click to Enlarge Source: Bloomberg Medical Properties Trust (NYSE:MPW) has properties that are leased on a net basis to operators that run the facilities and pay rent month after month for years. The portfolio has expanded dramatically over the recent year with only a small pause in the past year. But it continues to look to expand its portfolio with the right properties in an ever-expanding market.Revenues are climbing with gains running at over 11.30% in just the trailing year. And the funds from operations (FFO) which measures just the return rate from the cashflows from the property portfolio is ample at 11.60%, which is impressive for the REIT space. This contributes to an impressive return on its assets at 11.40% and is what delivers for shareholders with a return on equity of 24.30%.And the stock continues to reflect its performance as a company. Over the past ten years, the stock has delivered a total return of 994.12% for an average annual equivalent of 26.79%. It is a disciplined company when it comes to debt and leverage as its debt to capital is at only 47.00%. This provides the ability to easily service its current debts and provides eased access for credit to fund additional acquisitions. Valued at only 1.49 times its book value, MPW is a steal from a price-book (P/B) perspective. This ratio has climbed significantly over the trailing year, from 1.14 times back in October 2018.But it isn't just the P/B ratio that's rising, but the actual value of the assets. Over the past five years alone, the underlying book value per share has gone from $7.98 to a current $12.27, which represents an impressive gain of 53.76%. This is important as it shows genuine growth in the underlying company and not just the stock price. The dividend is currently at 25 cents per share and has been climbing in distribution by an average annual rate of 4.30% over the past five years. This equates to a current yield of 5.48%. * Top 7 Service Sector Stocks That Will Pay You to Own Them Medical Properties Trust makes for a great buy in the healthcare market (which should be purchased in a taxable account). This is due to the Tax Cuts and Jobs Act (TCJA) which provides a tax deduction of 20% of the dividend distribution for U.S. individual investors making the taxable equivalent yield even higher. Other Stocks to Play HealthcareInside the Profitable Investing model portfolios, I have the overall market for healthcare synthetically invested in the Vanguard Healthcare ETF (NYSEARCA:VHT), which remains a buy in a tax-free account. Then, in my Incredible Dividend Machine portfolio inside Profitable Investing, I have three more plays on healthcare …I have the drugmaker Merck (NYSE:MRK), which continues to perform for shareholders. And I have another drugmaker in Pfizer (NYSE:PFE), which follows the success of Merck. Further, I also have Ventas (NYSE:VTR), which as a real estate investment trust (REIT) that owns a series of senior healthcare and related housing care facilities. VTR is doing quite well with the general REIT sector as we move further into 2019.One of the smartest investment lessons that I learned, from one of my best stocks within Profitable Investing, is to capitalize when the opportunity arises. That is, take risks while you lock in revenues! And the aforementioned stocks should continue to position themselves into the thick of the rising healthcare spending market while paying out an ample and rising dividend.Neil George is the editor of Profitable Investing and does not have any holdings in the securities mentioned above. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Invincible Stocks Leading The Bull Market Higher * 5 Dow Jones Stocks Coming to Life * 7 of the Best High-Yield Funds for 2019 and Beyond Compare Brokers The post Invest in America's Rising Healthcare Costs With These Stocks appeared first on InvestorPlace.

  • 3 Dividend Stocks Perfect for Retirees
    Motley Fool2 days ago

    3 Dividend Stocks Perfect for Retirees

    Here's why these high-income stocks can be owned in retirement portfolios.

  • Healthcare Realty (HR) Prices Offering of 3.25M Common Stock
    Zacks6 days ago

    Healthcare Realty (HR) Prices Offering of 3.25M Common Stock

    Healthcare Realty's (HR) latest public offering of common stock will improve its financial flexibility and provide ample scope for deploying capital in accretive acquisitions.

  • InvestorPlace6 days ago

    7 ETFs to Buy to Ride the Longevity Economy

    Do you ever watch the Today Show? It frequently runs a segment where it celebrates the birthdays of people who are 100 years or older. As we are living longer, the number of celebrations has grown exponentially since Willard Scott started the practice in 1983. The economic effects of this demographic shift are tangible. InvestorPlace - Stock Market News, Stock Advice & Trading TipsSo, when I saw a recent article in Builder magazine that asked the question of what happens when more people live to 100 -- and more importantly, live to be a centenarian in relatively good health, there's money to made by investors. "The impact of what's known as the "longevity economy" -- defined as the purchasing power of those 55 and older -- is over $7.6 trillion in the United States alone," stated Builder contributor John McManus. "Many business leaders are recognizing that there are, and will continue to be, financial reasons to pay attention to these demographic shifts."While you could probably come up with a few names of companies that will benefit from an aging population, to save you some time, I thought I'd give you the answer on a silver platter with a few worth-while exchange-traded funds to consider. * The 10 Best Stocks to Buy for the Bull Market's Anniversary Here are seven ETFs to buy to ride the longevity economy. The Long-Term Care ETF (OLD)The meaning of the name behind the The Long-Term Care ETF (NASDAQ:OLD) is reasonably self-explanatory. OLD is an ETF from Janus Henderson (NYSE:JHG) that seeks to invest in companies around the world that are providing long-term care to an aging population. Tracking the Solactive Long-Term Care Index, OLD is a portfolio of 46 stocks that work in and around long-term care. The top ten holdings account for 68% of the fund's $16.5 million in total assets.Almost three years old, OLD's track record is still relatively short. However, over the past year, it did achieve an annual total return of 22.9% through Mar. 12; ten times the return of the S&P 500 over the same period.Charging 0.35% in expenses (or $35 annually per $10,000 invested), it has a nice mix of large and small companies, which means you're going to get a combination of large-cap dividend payers along with small- and mid-cap growth stocks. Oh, and don't forget, it benefits from an aging population. Global X Longevity Thematic ETF (LNGR)If you're going to invest in ETFs benefiting from the longevity economy, there is no more appropriate an investment than the Global X Longevity Thematic ETF (NASDAQ:LNGR), which tracks the Indxx Global Longevity Thematic Index. The index focuses on four longevity themes: Health care products, health care services, medical devices and senior homes. Within those four themes are 19 related industries. A company must generate at least 50% of its revenue from one of the four themes to qualify for inclusion. These are considered pure-play longevity companies. The index's goal is to assemble a portfolio of 100 companies. No stock can account for more than a 3% weight cap and a 0.3% weight floor. No industry can account for more than 60% of the portfolio. It's reconstituted and rebalanced annually in April. In existence since May 2016, LNGR has managed to attract $17.1 million in assets under management, which isn't much, but given how competitive the ETF space is, it's better than many other niche funds. * 10 Dividend Stock Winners Charging 0.50% annually, ETF specialists would probably call it expensive given almost 70% of the portfolio is invested in two industries -- healthcare equipment and biotechnology, which you can get elsewhere for less. iShares Residential Real Estate Capped ETF (REZ) While the iShares Residential Real Estate Capped ETF (NYSEARCA:REZ) is a play on real estate, two of the fund's top ten holdings are Ventas (NYSE:VTR) and Welltower (NYSE:WELL), two of this country's biggest owners of healthcare real estate. REZ has 33% of its $421 million in net assets invested in healthcare REITs, making the longevity economy an important reason why this ETF should do well in the next 5-10 years. In existence since May 2007, REZ has delivered for shareholders, generating an annualized total return of 18%, 155 basis points higher than the S&P 500. As its name suggests, its primary focus is to invest in residential real estate in the U.S., which accounts for 49% of the ETFs net assets. As far as real estate ETFs go, at 0.48% annually, it's not cheap, but it has at least outperformed the index and its real estate peers. Vanguard Health Care ETF (VHT)If you're going to write an article about ETFs benefiting from the longevity economy, or any economy for that matter, you've got to include Vanguard in the mix, if only because of its lower costs. The Vanguard Health Care ETF (NYSEARCA:VHT) charges a paltry 0.10% for its portfolio of 385 healthcare stocks. Of the industries it invests in, the top four by weight are pharmaceuticals (29%), healthcare equipment (21%), biotechnology (20%) and managed healthcare (11%). VHT's top ten holdings account for 44% of the fund's $10.3 billion in total net assets making it the biggest of the seven ETFs mentioned in this article. If you're going to focus on the longevity economy, VHT makes total sense as an anchor for your entire portfolio of ETFs because it brings size, it brings low fees and it delivers performance. * 7 Inexpensive, High-Dividend ETFs to Buy A decade ago, if you invested $10,000 in VHT, today it would be worth almost $51,000. You absolutely should have this ETF in your portfolio. SPDR S&P Insurance ETF (KIE)One of the things a lot of us buy to protect our family's assets is life insurance. Unfortunately, when we think of life insurance, the first thing that comes to mind is death. And when we think of death, we think of getting old. The SPDR S&P Insurance ETF (NYSEARCA:KIE) got its start in November 2005. More than 13 years later, it has total net assets of $714 million, a reasonable amount for a sector ETF. Like a lot of these ETFs, it has a smaller number of holdings with just 48. Life and health insurers account for 28% of the portfolio, the second-largest weighting, behind property and casualty insurance at 40%. Charging a reasonable 0.35% annually, KIE tracks the S&P Insurance Select Industry Index, an index that represents the insurance segment of the S&P Total Market Index, which in addition to life and health insurance and property and casualty insurance, invests in insurance brokers, multi-line insurance companies and reinsurance companies. The index is comprised of insurance stocks that have a float-adjusted market cap of $2 billion or more. The index's modified equal weighting ensures that investors get both company diversification by type of insurance and size of the company. ARK Innovation ETF (ARKK)The ARK Innovation ETF (NASDAQ:ARKK) has quite the reputation having been named ETF of the Year in 2017. Actively managed, it focuses on companies relying on disruptive innovation to drive their growth. ARKK's largest holding is Tesla (NYSEARCA:TSLA) with a weighting of 8.4%. Perhaps you've heard of Catherine Wood, the ETF's portfolio manager? She's gained a lot of notoriety for writing a letter to Tesla CEO Elon Musk last August asking him not to take the company private. I wrote about her shortly after that letter made the rounds. With more than $1 billion in total net assets in a little over four years, Wood has done an excellent job putting ARK Investment Management on the map, the business she started in 2014 after working for others for more than 30 years. If you like ETFs that invest across all market caps, you'll like ARKK. It puts almost half of its assets in small- and mid-cap stocks, limiting its number of holdings between 35-50 of its best ideas. * 7 Dividend Stocks With Big Yields Paying 0.75% for arguably one of the best tech investors in America, this is the star of the seven ETFs to buy I've listed. Principal Millennials Index ETF (GENY)Nobody likes getting old so it stands to reason that if you're going to bet on the longevity economy, it probably makes sense to hedge your bets a little by investing in the Principal Millennials Index ETF (NASDAQ:GENY), an ETF that invests in companies that are impacted by the spending and lifestyle of people born between 1980 and the mid-2000s. While it has taken the boomers a little while to understand where the Millennials are coming from, I can assure you we boomers (I'm 54 and at the very tail end of the baby boom) recognize the economic impact that this demographic is having on companies, big and small. There's money to be made from them. The ETF tracks the Nasdaq Global Millennial Opportunity Index, a group of approximately 100 stocks that derive a significant chunk of their revenue from Millennial consumption. As a result, its holdings list is much different than the typical broad-based ETF. It charges 0.45%, That's a reasonable fee considering the three portfolio managers bring an average of 23 years of industry experience to the table, it's going to surprise a lot of investors in the future who view it merely as a fad. Expected to spend $10 trillion over their lifetime, Millennials are the real deal. And so is GENY. As of this writing, Will Ashworth did not hold a position in any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 15 Stocks Sitting on Huge Piles of Cash * The 10 Best Stocks to Buy for the Bull Market's Anniversary * 7 Dividend Stocks With Big Yields Compare Brokers The post 7 ETFs to Buy to Ride the Longevity Economy appeared first on InvestorPlace.

  • Markit8 days ago

    See what the IHS Markit Score report has to say about Ventas Inc.

    Ventas Inc NYSE:VTRView full report here! Summary * Perception of the company's creditworthiness is negative * Bearish sentiment is low * Economic output in this company's sector is expanding Bearish sentimentShort interest | PositiveShort interest is low for VTR with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | NeutralETF activity is neutral. ETFs that hold VTR had net inflows of $4.49 billion over the last one-month. While these are not among the highest inflows of the last year, the rate of inflow is increasing. Economic sentimentPMI by IHS Markit | PositiveAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Financials sector is rising. The rate of growth is strong relative to the trend shown over the past year. Credit worthinessCredit default swap | NegativeThe current level displays a negative indicator. VTR credit default swap spreads are near their highest levels for the past 1 year, which indicates the market's more negative perception of the company's credit worthiness.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • Ventas (VTR) Down 3.8% Since Last Earnings Report: Can It Rebound?
    Zacks10 days ago

    Ventas (VTR) Down 3.8% Since Last Earnings Report: Can It Rebound?

    Ventas (VTR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • GlobeNewswire15 days ago

    Report: Developing Opportunities within Celanese, Genuine Parts, UnitedHealth Group, Ventas, CNO Financial Group, and Multi-Color — Future Expectations, Projections Moving into 2019

    NEW YORK, March 06, 2019 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.

  • Business Wire19 days ago

    Ventas to Participate in Citi 2019 Global Property CEO Conference

    Ventas, Inc. (VTR) management will make a presentation regarding the Company at the Citi 2019 Global Property CEO Conference (the “Citi Conference”) in Hollywood, Florida on March 5, 2019 at 8:50 a.m. Eastern Time. The presentation will be audio webcast and may be accessed through the Company’s website at www.ventasreit.com/investor-relations. Any Company written materials accompanying the presentation or the Company’s meetings with certain investors at the Citi Conference will be available on the Company’s website starting at 7 a.m. Eastern Time on March 4.

  • Take these 3 steps to climate-proof your stock-market investments
    MarketWatch21 days ago

    Take these 3 steps to climate-proof your stock-market investments

    Extreme weather is on the upswing. Here’s how to mitigate the impact of climate change on your portfolio.

  • HT or VTR: Which Is the Better Value Stock Right Now?
    Zacks23 days ago

    HT or VTR: Which Is the Better Value Stock Right Now?

    HT vs. VTR: Which Stock Is the Better Value Option?

  • Mack-Cali's (CLI) Q4 FFO Meets, Revenues Miss Estimates
    Zacks27 days ago

    Mack-Cali's (CLI) Q4 FFO Meets, Revenues Miss Estimates

    Mack-Cali Realty's (CLI) fourth-quarter 2018 results indicate softness in its office portfolio. In fact, subdued leasing activity and decline in same-store cash net operating income disappoint.

  • SITE Centers (SITC) Q4 FFO Beats, Revenues Miss Estimates
    Zacks27 days ago

    SITE Centers (SITC) Q4 FFO Beats, Revenues Miss Estimates

    While SITE Centers (SITC) posts better-than-expected results, backed by healthy leasing activity, rent and same-store net operating income (NOI) growth, declining revenues remains a concern.

  • Lamar Advertising (LAMR) Q4 AFFO Tops Estimates, Revenues Up
    Zacks27 days ago

    Lamar Advertising (LAMR) Q4 AFFO Tops Estimates, Revenues Up

    Lamar Advertising (LAMR) witnesses bottom-line growth on higher revenues and solid operating income in the fourth quarter.

  • Host Hotels' (HST) Q4 FFO Beats Estimates, Revenues Up Y/Y
    Zacks28 days ago

    Host Hotels' (HST) Q4 FFO Beats Estimates, Revenues Up Y/Y

    Host Hotels & Resorts' (HST) Q4 results reflect improvements in food and beverage revenues and productivity gains. Further, year-over-year growth in comparable hotel RevPAR is encouraging.

  • Business Wire29 days ago

    Ventas Announces Pricing of Senior Notes Offering

    Ventas, Inc. (VTR) (“Ventas” or the “Company”) announced today that it has priced a public offering of $400 million aggregate principal amount of 3.500% Senior Notes due 2024 and $300 million aggregate principal amount of 4.875% Senior Notes due 2049 (collectively, the “Notes”) at 99.878% and 99.770% of the respective principal amounts. The Notes are being issued by Ventas Realty, Limited Partnership (“Ventas Realty”), a wholly owned subsidiary of the Company, and will be guaranteed, on a senior unsecured basis, by the Company. The Company expects to use the net proceeds from the offering for working capital and other general corporate purposes, which may include repaying additional existing indebtedness.

  • HCP Meets Q4 FFO Estimates, Misses on Revenues, Issues View
    Zackslast month

    HCP Meets Q4 FFO Estimates, Misses on Revenues, Issues View

    HCP's fourth-quarter 2018 results marred by continued decline in senior-housing operating portfolio cash net operating income.

  • Iron Mountain (IRM) Tops Q4 FFO Estimate, Misses on Revenues
    Zackslast month

    Iron Mountain (IRM) Tops Q4 FFO Estimate, Misses on Revenues

    Iron Mountain Incorporated's (IRM) performance in fourth-quarter 2018 reflects decent organic growth in storage and services revenues. The company issues outlook for 2019 as well.

  • Equinix (EQIX) Q4 FFO Surpasses Estimates, Revenues Up Y/Y
    Zackslast month

    Equinix (EQIX) Q4 FFO Surpasses Estimates, Revenues Up Y/Y

    Equinix (EQIX) records year-over-year growth in revenues backed by strong performance of the company's Americas, EMEA and Asia-Pacific portfolios.

  • Is Ventas, Inc.’s (NYSE:VTR) CEO Salary Justified?
    Simply Wall St.last month

    Is Ventas, Inc.’s (NYSE:VTR) CEO Salary Justified?

    Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! Deb Cafaro became the CEO of Ventas,Read More...

  • TheStreet.comlast month

    Ventas Is Showing Some Softness Now, Raise Sell Stop Protection

    This healthcare REIT just reported a good quarter and has an attractive dividend yield, so Cramer wanted to talk with management to get a better feel for what's going on. Cafaro said that this year will be a pivotal year to return Ventas to growth.

  • CNBClast month

    Cramer Remix: Don't let Wall Street convince you there's a 'Fed-induced bubble'

    Jim Cramer breaks down the real reasons behind the market's latest moves.

  • Thomson Reuters StreetEventslast month

    Edited Transcript of VTR earnings conference call or presentation 8-Feb-19 3:00pm GMT

    Q4 2018 Ventas Inc Earnings Call

  • Welltower (WELL) Misses Q4 FFO Estimates, Reaffirms '19 View
    Zackslast month

    Welltower (WELL) Misses Q4 FFO Estimates, Reaffirms '19 View

    Welltower's (WELL) Q4 results reflect healthy same-store net operating income (SSNOI) performance across all of its operating segments.

  • Cramer's Exec Cut: A window into the world's top companies
    CNBC Videos28 days ago

    Cramer's Exec Cut: A window into the world's top companies

    Jim Cramer gets insight on how execs at Shopify, Hasbro, Twilio and more view the future of their industries.

  • Ventas CEO talks health-care REIT's four-pronged 'pivot to growth'
    CNBC Videoslast month

    Ventas CEO talks health-care REIT's four-pronged 'pivot to growth'

    Jim Cramer sits down with Ventas Chairman and CEO Deb Cafaro, who details her company's plan to drive growth through innovation and external growth.